About this collection

Iron deficiency is common in patients with heart failure and is probably underdiagnosed in clinical practice. This module addresses the assessment and management of this common condition. It also discusses various studies and the latest guidelines regarding HF and iron deficiency.

This module provides an overview of lowering cholesterol using a dietary approach. Key learning points for healthcare professionals include the importance of preventing cardiovascular disease, the benefits of a cholesterol-lowering diet and the role of plant stanols and sterols.

The goal of this module is to review the diagnosis, classification and treatment of patients with lipid disorders based on the updated 2019 European Society of Cardiology Guidelines. The content identifies key features in the recognition and treatment of lipid disorders in both primary and secondary prevention in a step wise approach. It also reviews new emerging treatments for resistant dyslipidaemias including the use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and imaging techniques for risk stratification.

Learning objectives of this module:

• Understand the principal causes (AL amyloidosis and ATTR) and underlying pathophysiology of cardiac amyloidosis 
• Identify patients to screen for cardiac amyloidosis and the subsequent diagnostic process 
• Develop insight into the management of cardiac amyloidosis and its underlying causes

An overview of the latest approaches and evidence in treating iron deficiency in patients with cardiovascular issues.

This CPD module gives a comprehensive expert overview of the latest treatment strategies for hypercholesterolaemia.